REG1A and hepatocellular carcinoma: One such receptor is the hepatitis B virus X protein (HBV X protein), which has been observed to upregulate CD46 expression, thereby enabling hepatocellular carcinoma cells and hepatocytes to evade from complement-mediated attack (62).